Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis-Reference-Cited by-同舟云学术

Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis

Published:2020-12 Issue:13 Volume:18 Page:2952-2961.e8
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Dulai Parambir S.^ORCID,Singh Siddharth,Vande Casteele Niels^ORCID,Meserve Joseph^ORCID,Winters Adam,Chablaney Shreya,Aniwan Satimai,Shashi Preeti,Kochhar Gursimran,Weiss Aaron,Koliani-Pace Jenna L.,Gao Youran,Boland Brigid S.,Chang John T.,Faleck David^ORCID,Hirten Robert,Ungaro Ryan,Lukin Dana^ORCID,Sultan Keith^ORCID,Hudesman David,Chang Shannon,Bohm Matthew,Varma Sashidhar^ORCID,Fischer Monika^ORCID,Shmidt Eugenia^ORCID,Swaminath Arun,Gupta Nitin^ORCID,Rosario Maria,Jairath Vipul,Guizzetti Leonardo,Feagan Brian G.,Siegel Corey A.,Shen Bo,Kane Sunanda,Loftus Edward V.^ORCID,Sandborn William J.,Sands Bruce E.^ORCID,Colombel Jean-Frederic,Lasch Karen,Cao Charlie

Funder

American Gastroenterology Association

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference16 articles.

1. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;N Engl J Med,2013

2. Vedolizumab in IBD-lessons from real-world experience: a systematic review and pooled analysis;Engel;J Crohns Colitis,2018

3. Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease;Barre;Aliment Pharmacol Ther,2018

4. Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis;Waljee;Aliment Pharmacol Ther,2018

5. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement;Collins;Ann Intern Med,2015

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina;Biomolecules and Biomedicine;2024-09-06

2. Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti Integrins;The Korean Journal of Gastroenterology;2024-08-25

3. Peripheral blood DNA methylation signatures predict response to vedolizumab and ustekinumab in adult patients with Crohn’s disease: The EPIC-CD study;2024-07-25

4. How close are we to a success stratification tool for improving biological therapy in ulcerative colitis?;Expert Opinion on Biological Therapy;2024-06-02

5. Diagnosis and management of inflammatory bowel disease;Journal of Evidence-Based Medicine;2024-06